Gen-Probe Deal to Acquire Tepnel Expected to be Effective in April

Tepnel's shareholders will vote on the deal next month, with the $132.1 million offer expected to take effect in April.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories